Keyphrases
Androgens
100%
Androgen Exposure
66%
Interferon-β (IFN-β)
66%
Anabolic Steroids
54%
Matched Cohort Study
48%
Incidence Rate
34%
Infection Risk
33%
Meningioma
33%
Early childhood
33%
Acute Kidney Injury
33%
In Utero Exposure
33%
Central Serous Chorioretinopathy
33%
Psychiatric Morbidity
33%
Risk of Malignancy
33%
Abusers
33%
Androgen Abuse
33%
Tobramycin
33%
Self-controlled Study
33%
Psoriasis Pathogenesis
33%
Registry-based
33%
Psoriasis
33%
Male Infertility
33%
Multiple Sclerosis
28%
Breast Cancer
22%
Male Control
19%
Fitness Centers
19%
Prostate Cancer
18%
Intraosseous
16%
Hemodialysis
16%
Multiple Treatments
16%
Rate Ratio
14%
Hospital Admission
13%
Antibiotic Prescription
13%
Denmark
12%
Treatment Initiation
11%
Anti-doping
11%
Interferon-β Treatment
11%
Confidence Interval
11%
Psychiatric Comorbidity
8%
National Register
8%
High Incidence
8%
Antipsychotics
8%
Fracture-related Infection
8%
Antidepressant Use
8%
Therapeutic Agents
8%
Steroid Use
8%
Healthy Individuals
8%
2-year Follow-up
8%
Socioeconomic Factors
8%
50 Years Old
8%
Pharmacology, Toxicology and Pharmaceutical Science
Beta Interferon
66%
Cohort Study
48%
Infection
41%
Androgen
33%
Psoriasis
33%
Anabolic Steroid
33%
Acute Kidney Failure
33%
Tobramycin
33%
Multiple Sclerosis
30%
Doping
20%
Prostate Cancer
16%
Intraosseous Infusion
16%
Breast Cancer
16%
Hemodialysis
16%
Malignant Neoplasm
13%
Antibiotics
13%
Comorbidity
8%
Antidepressant
8%
Prevalence
8%
Typical Antipsychotic
8%
Anxiolytic
8%
Pharmacokinetics
8%
All Cause Mortality
6%
Antibiotic Agent
6%
Dose-Response Relationship
6%
Mortality Rate
6%
Childhood Mortality
6%
Medicine and Dentistry
Androgen
100%
Cohort Analysis
66%
Meningioma
33%
Male Fertility
33%
Tobramycin
33%
Acute Kidney Injury
33%
Cancer
33%
Anabolic Agent
20%
Breast Cancer
16%
Hemodialysis
16%
Kidney Function
16%
Intraosseous Infusion
16%
Prostate Cancer
16%
Malignant Neoplasm
13%
Doping
10%
Pharmacokinetics
8%
Infection
8%
Assisted Reproduction
6%
Prevalence
6%
